Oncocyte Corp Annual Earnings Per Share, Basic in USD/shares from 2021 to 2023

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Oncocyte Corp quarterly/annual Earnings Per Share, Basic history and growth rate from 2021 to 2023.
  • Oncocyte Corp Earnings Per Share, Basic for the quarter ending September 30, 2024 was -0.98 USD/shares, a 21% decline year-over-year.
  • Oncocyte Corp Earnings Per Share, Basic for the twelve months ending September 30, 2024 was -4.74 USD/shares, a 58.9% increase year-over-year.
  • Oncocyte Corp annual Earnings Per Share, Basic for 2023 was -3.75 USD/shares, a 71.7% increase from 2022.
  • Oncocyte Corp annual Earnings Per Share, Basic for 2022 was -13.3 USD/shares, a 1740% decline from 2021.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$4 +$9.50 +71.7% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-16
2022 -$13 -$13 -1740% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-16
2021 -$1 Jan 1, 2021 Dec 31, 2021 10-K 2023-04-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.